Diseases, Conditions, Syndromes

Nasal vaccine against COVID-19 prevents infection in mice

Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible ...

Diseases, Conditions, Syndromes

Ebola vaccine tests hailed a success

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

Diseases, Conditions, Syndromes

Researchers develop Ebola vaccine effective in a single dose

An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola ...

Medical research

Toward a vaccine for Ebola

On August 26, 1976, a time bomb exploded in Yambuku, a remote village in Zaire, (now the Democratic Republic of the Congo). A threadlike virus known as Ebola had emerged, soon earning a grim distinction as one of the most ...

Medical research

Single vaccines to protect against both rabies and Ebola

Researchers from Thomas Jefferson University, among other institutions, including the National Institute of Allergy and Infectious Diseases, have developed single vaccines to protest against both rabies and the Ebola virus.

Diseases, Conditions, Syndromes

Uganda extends lockdowns as Ebola spreads

Uganda on Saturday extended a three-week lockdown on two districts at the center of an Ebola outbreak which has claimed over 50 lives, curbing travel and closing public places.

Diseases, Conditions, Syndromes

Monkey study: Ebola vaccine works, needs booster

New monkey studies show that one shot of an experimental Ebola vaccine can trigger fast protection, but the effect waned unless the animals got a booster shot made a different way.

Diseases, Conditions, Syndromes

New testing of Ebola vaccine to start next month in Canada

An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.

page 1 from 16